Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
15/04/2026 02:51
April 15 (Reuters) - Noxopharm Ltd NOX.AX: NOXOPHARM APPOINTS DR OLIVIER LACZKA AS NEW CEO Further company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential